Activhealth.com.sg2

Q. DOES EFAMOL® EPO CAUSE ANY SIDE EFFECTS?
A.
Clinical studies using Efamol® EPO, in a wide range of diseases have included monitoring
for potential side effects. Outside the context of clinical trials, well over 1,000,000 Kg of EPO
have been taken since the mid 1970's. This wide consumer use has provided ample
opportunity to collect reliable information about any side effects that may be associated with
the product. Side effects are very rare and may include headache, nausea, soft stool,
diarrhoea or other gastrointestinal disturbances. The digestive upsets can usually be
eliminated by taking the product with food and/or reducing the dose to one capsule per day
and then slowly increasing the dose up to the recommended amount over the course of a
week. People taking the product on an empty stomach tend to have more digestive side
effects.
Q. CAN I TAKE EFAMOL® EPO WITH OTHER MEDICATIONS OR
SUPPLEMENTS?
A.
There are no known interactions of Efamol® EPO with other natural health products. You
should consult a qualified health care provider if you are taking anticoagulants, epileptogenic
drugs, ASA, or phenothiazines. Anyone under medical supervision or taking medication
should consult their health care provider before taking any supplement including Efamol®
EPO.
Q. DOES EFAMOL® EPO AFFECT ESTROGEN LEVELS?
A.
No. Various hormone levels were monitored during clinical studies using Efamol® EPO to
treat premenstrual syndrome. No changes were found in the levels of follicle stimulating
hormone, leutinizing hormone, prolactin, progesterone, estradiol (estrogen) or testosterone1.
1.
Puolakka J, Mäkäräinen L, Viinikka L, Ylikorkala O Biochemical and clinical effects of treating the PMS with prostaglandin synthesis precursors. The Journal of Reproductive Medicine 1985;Vol.30, No.3 March: 149-153. Q. IS EVENING PRIMROSE OIL FATTENING?
A.
No. Each 500 mg capsule contains approximately 5 calories.
Q. DO I TAKE EFAMOL® EPO UNTIL I GET BETTER AND THEN STOP TAKING
IT?
A.
Efamol® EPO is considered a daily supplement and should be taken as long as you want
to maintain a satisfactory condition. Fatty acid supplementation does not "fix" a problem in
the body. Instead, it provides nutrients that your body needs to by-pass the problem.
Therefore, if you stop taking the supplement, the problem will recur.
Q. WHO SHOULD NOT TAKE EFAMOL® EPO?
A.
People with blood clotting disorders that are not under qualified health care supervision.
Q. DO YOU RECOMMEND ANY OTHER PRECAUTIONS WHEN TAKING
EFAMOL® EPO?
A.
EPO has been extensively tested in a whole range of toxicity trials that included
measurements of acute toxicity, chronic toxicity, carcinogenicity and reproductive toxicity.
Results of all these studies showed a lack of toxicity. This is not surprising since evening
primrose oil is composed of fatty acids that are normal components of your body.
Q. HOW LONG WILL IT TAKE BEFORE I SEE RESULTS?
A.
It normally takes about twelve weeks before you will notice an improvement in your
health. Fatty acid supplementation provides nutrients that have been depleted from your
body and correcting this takes time to achieve maximum benefit. Therefore, allow at least
three months before evaluating whether the treatment is effective for you.

Source: http://www.activhealth.com.sg/downloads/Efamol_Evening_Primrose_Oil_FAQ.pdf

forms.co.ke

R………………………… Receiving Officer OMBI LA KUTAKA PASPOTI YA KENYA APPLICATION FOR A KENYA PASSPORT Signature.………………………. Stamp …………………………. Majina Kamili } Full Names Indexing Officer Tafadhali soma maagizo kwa makini kabla ya kujaza fomu Please read instructions carefully before completing the form Signa

Microsoft word - lung flute_therapeutic study manuscript_final.doc

Comparison of the Lung Flute® with the Acapella® in the Treatment of COPD with Sanjay Sethi, M.D. 1,2 Jane Maloney, R.N. 2 Lori Grove, B.S. 2 1 VA WNY Health Care System, Buffalo, NY and 2 University at Buffalo, SUNY, Corresponding Author: Sanjay Sethi, M.D. Source of support: Medical Acoustics, Inc. ABSTRACT Chronic obstructive pulmonary disease (COPD) is characterized by mucus hypers

Copyright © 2010-2014 Drug Shortages pdf